Join for Free!
112058 members
table of contents table of contents

To directly radiolabel an anti-hepatoma mAb fragment HAb18 F(ab’)2 with 99mTc …

Biology Articles » Biophysics » Medical Biophysics » Direct technetium-99m labeling of anti-hepatoma monoclonal antibody fragment: a radioimmunoconjugate for hepatocellular carcinoma imaging » References

- Direct technetium-99m labeling of anti-hepatoma monoclonal antibody fragment: a radioimmunoconjugate for hepatocellular carcinoma imaging

1    Rhodes BA.Direct labeling of proteins with 99mTc.Nucl Med Biol,1991;18:667-676
2    Childs RL, Hnatowich DJ. Optimum condition for labeling of DTPA coupled antibodies with Technetium-99m.
      J Nucl Med, 1985;26:293-299
3    Ultee ME, Bridger GJ, Abrams MJ, Longley CB, Burton CA, Larsen SK, Henson GW, Padmanabhan S, Gaul FE, Schwartz 
      DA.Tumor imaging with technetium-99m-labeled hydrazinonicotinamide-Fab’ conjugates.J Nucl Med,1997;38:133-138
4    Joiris E, Bastin B, Thornback JR. A new method for labeling of monoclonal antibodies and their fragments with 
      technetium-99m.Nucl Med Biol,1991;18:353-356
5    Eckelman WC, Meinken G, Richards P. 99mTc-human serum albumin. J Nucl Med, 1971;12:707-710
6    John E, Thakur ML, Wilder S, Alauddin MM, Epstein AL. Technetium-99m-labeled monoclonal antibodies: influence of
      technetium-99m binding sites.J Nucl Med, 1994;35:876-881
7    Mather SJ, Ellison D. Reduction-mediated technetium-99m labeling of monoclonal antibodies.J Nucl Med, 
8    Rhodes BA, Zamora PO, Newell KD, Valdez EF. Technetium-99m labeling of murine monoclonal antibody fragments.
      J Nucl Med, 1986;27:685-693
9    Pauwels EKJ, Welling MM, Feitsma RIJ, Atsma DE, Nieuwenhuizen W. The labeling of proteins and LDL with 99mTc: 
      a newdirect method employing KBH4 and stannous chloride. Nucl Med Biol, 1993;20:825-833
10  Schwarz SW, Connett JM, Anderson CJ, Rocque PA, Philpott GW, Guo LW, Welch MJ. Evaluation of a direct method for
      technetium labeling intact and F(ab’)2 lA3, an anticolorectal monoclonal antibody.Nucl Med Biol, 1994;21:619-626
11  Qi P, Muddukrishna SN, Both RT, Rahn J, Chen A. Direct 99mTc-labeling of antibodies by sodium dithionite reduction,
      and role of ascorbate as a stabilizer in cysteine challenge. Nucl Med Biol, 1996;23:827-835
12  Hnatowich DJ, Virzi F, Fogarasi M, Rusckowski M, Winnard-JR P. Can a cysteine challenge assay predict the in vivo 
      behaviorof 99mTc-labeled antibodies. Nucl Med Biol, 1994;21:1035-1044
13  Sykes TR, Woo TK, Baum RP, Qi P, Noujaim AA. Direct labeling of monoclonal antibodies with technetium 99m by
      photoactivation.J Nucl Med, 1995;36:1913-1922
14  Nakayama M, Wada M, Araki N, Ginoza Y, Terahara T, Harada K, Sugh A, Tomiguchi S,Kojima A, Hara M, Takahashi M.
      Direct 99mTc labeling of human immunoglobulin with an insoluble macromolecular Sn () complex.
      Nucl Med Biol, 1995;22:795-802
15  Rosenzweig HS, Ranadive GN, Seskey T, Epperly MW, Bloomer WD. A novel method for the non-chromatographic 
      purificationof technetium-99m-labeled monoclonal antibodies:a study with B72.3 monoclonal antibody. Nucl Med 
16  Alauddin MM, Khawli LA, Epstein AL. An improved method of direct labeling monoclonal antibodies with 99mTc.
      Nucl Med Biol, 1992;19:445-454
17  Gooden CSR, Snook DE, Maraveyas A, Rowlinson BG, Peters AM, Epenetos AA. Direct technetium 99m labeling of three
      anticancer monoclonal antibodies: stability, pharmacokinetics and imaging.J Nucl Med, 1995;36:842-849
18  Chen ZN, Liu YF, Yang JZ. Anti human hepatocellular carcinoma monoclonal antibody and immunohistochemical location
      of associated antigen P60.Dankelong Kangti Tongxun, 1989;2:33-36
19  Qiu K, Chen ZN, Liu ZG, Wang Q, He FC, Qu P, Mi L, Sui YF, Liu YF. Preparation of anti hepatoma McAb HAb18 F(ab’)2
      and Fab fragments by papainic digestions in different conditions.Disi Junyi Daxue Xuebao, 1995;16:414-417
20  Ellman GL. Tissue sulphydryl groups.Arch Bioch Biophys, 1959;82:70-77
21  Thrall JH, Freitas JE, Swanson D, Rogers WL, Clare JM, Brown ML, Pitt B. Clinical comparison of cardiac blood pool
      visualization with technetium-99m red blood cells labeled in vivo and with technetium-99m human serum albumin.
      J Nucl Med, 1978;19:796-803
22  Lindmo T, Boven E, Cuttitta F, Fedorko J, Bunn-Jr PA. Determination of the immunoreactive fraction of radiolabeled
      monoclonal antibodies by linear extrapolation to binding at infinite antigen excess.J Immun Med, 1984;72:77-89
23  Morrison RT, Lyster DM, Alcorn L, Rhodes BA, Breslow K, Burchiel SW. Radioimmunoimaging with 99mTc monoclonal
      antibodies: clinical studies. Int J Nucl Med Biol, 1984;11:184-188
24  Bian HJ, Chen ZN, Deng JL, Duan XD, Mi L, Yu XL, Xu LQ. Direct labeling of anti hepatoma monoclonal antibody fragment
      with 99mTc by an improved pretinning method. Tongweisu, 1999;12:90-94
25  Granowska M, Mather SJ, Britton KE, Bentley S, Richman P, Phillips RKS, Northover JMA. 99mTc 
      radioimmunoscintigraphyof colorectal cancer. Br J Cancer, 1990;62(Suppl ):30-33
26  Hnatowich DJ, Mardirossian G, Rusckowski M, Fogarasi M, Virzi F, Winnard-Jr P. Directly and indirectly technetium-
      99m-labeled antibodies-a comparison of in vitro and animal in vivo properties. J Nucl Med, 1993;34:109-119
27  Behr TM, Becker WS, Sharkey RM, Juweid ME, Dunn RM, Bair HJ, Wolf FG, Goldenberg DM. Reduction of renal uptake 
      ofmonoclonal antibody fragments by amino acid infusion. J Nucl Med, 1996;37:829-833

rating: 0.00 from 0 votes | updated on: 28 Nov 2008 | views: 5297 |

Rate article: